July 2, 2025 · Form 4 insider transaction
Onyia Jude bought 20,362 shares of Neurocrine Biosciences, Inc. at $84.74 per share, a transaction worth $1.73M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.